2023 Volume 43 Issue 5 Pages 859-862
Post-pancreatectomy hemorrhage (PPH) associated with pancreatic fistula has a high fatality rate and requires immediate management via interventional radiology. Transcatheter arterial embolization has been considered as the treatment of first choice for PPH, but liver abscess, liver failure, and intestinal necrosis due to insufficient blood flow to the peripheral organs may occur as complications after embolization. Recently, the usefulness of covered stenting for vascular injuries has been reported. However, there are no guidelines concerning the selection of and duration of treatment with antiplatelet agents for preventing stent occlusion. The safety of antiplatelet agents and their efficacy against stent occlusion and the long-term outcomes after stenting for PPH remain unknown. The main difference between stenting for acute coronary syndromes and carotid stenosis and stenting for PPH is the high risk of occurrence of bleeding and perivascular infection in the latter case. Use of antiplatelet agents should be carefully evaluated when stenting is performed in the presence of hemorrhage. Herein, we describe our experience in cases of stenting performed for PPH from the hepatic artery and the use of antiplatelet agents.
